Cargando…

P409 Monitoring adherence to nebulised therapies during the first UK lockdown and school closure period of the COVID-19 pandemic in children with cystic fibrosis

Detalles Bibliográficos
Autores principales: Smith, C., McCormack, P., Walsh, A., Southern, K.W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Cystic Fibrosis Society. Published by Elsevier B.V. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250903/
http://dx.doi.org/10.1016/S1569-1993(23)00779-8
_version_ 1785055859415449600
author Smith, C.
McCormack, P.
Walsh, A.
Southern, K.W.
author_facet Smith, C.
McCormack, P.
Walsh, A.
Southern, K.W.
author_sort Smith, C.
collection PubMed
description
format Online
Article
Text
id pubmed-10250903
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher European Cystic Fibrosis Society. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-102509032023-06-09 P409 Monitoring adherence to nebulised therapies during the first UK lockdown and school closure period of the COVID-19 pandemic in children with cystic fibrosis Smith, C. McCormack, P. Walsh, A. Southern, K.W. J Cyst Fibros Posters European Cystic Fibrosis Society. Published by Elsevier B.V. 2023-06 2023-06-09 /pmc/articles/PMC10250903/ http://dx.doi.org/10.1016/S1569-1993(23)00779-8 Text en Copyright © 2023 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Posters
Smith, C.
McCormack, P.
Walsh, A.
Southern, K.W.
P409 Monitoring adherence to nebulised therapies during the first UK lockdown and school closure period of the COVID-19 pandemic in children with cystic fibrosis
title P409 Monitoring adherence to nebulised therapies during the first UK lockdown and school closure period of the COVID-19 pandemic in children with cystic fibrosis
title_full P409 Monitoring adherence to nebulised therapies during the first UK lockdown and school closure period of the COVID-19 pandemic in children with cystic fibrosis
title_fullStr P409 Monitoring adherence to nebulised therapies during the first UK lockdown and school closure period of the COVID-19 pandemic in children with cystic fibrosis
title_full_unstemmed P409 Monitoring adherence to nebulised therapies during the first UK lockdown and school closure period of the COVID-19 pandemic in children with cystic fibrosis
title_short P409 Monitoring adherence to nebulised therapies during the first UK lockdown and school closure period of the COVID-19 pandemic in children with cystic fibrosis
title_sort p409 monitoring adherence to nebulised therapies during the first uk lockdown and school closure period of the covid-19 pandemic in children with cystic fibrosis
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250903/
http://dx.doi.org/10.1016/S1569-1993(23)00779-8
work_keys_str_mv AT smithc p409monitoringadherencetonebulisedtherapiesduringthefirstuklockdownandschoolclosureperiodofthecovid19pandemicinchildrenwithcysticfibrosis
AT mccormackp p409monitoringadherencetonebulisedtherapiesduringthefirstuklockdownandschoolclosureperiodofthecovid19pandemicinchildrenwithcysticfibrosis
AT walsha p409monitoringadherencetonebulisedtherapiesduringthefirstuklockdownandschoolclosureperiodofthecovid19pandemicinchildrenwithcysticfibrosis
AT southernkw p409monitoringadherencetonebulisedtherapiesduringthefirstuklockdownandschoolclosureperiodofthecovid19pandemicinchildrenwithcysticfibrosis